Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-15

Clinical Trial Update: Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation

View source ↗

Summary

A completed clinical trial assessed the effect on Restless Legs Syndrome symptom severity after switching patients who experienced augmentation to Neupro (rotig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neupro (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Restless Legs Syndrome | Status: COMPLETED | Results posted: 2014-08-15